Peripheral Arterial Disease Trial, Recruiting NCT06711120 Sponsor: Chengdu University of Traditional Chinese Medicine Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06711120
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 90 years old
  • People who have been diagnosed with primary varicose veins in the lower legs, rated at a certain level of severity (a medical grading called C2–C6), where treatment of one or both of the main leg veins is needed
  • People experiencing at least one of these symptoms related to their varicose veins: swelling, pain, burning sensation, heaviness, easy fatigue, itchy skin, or night cramps
  • People whose leg veins have been found to have faulty valves that allow blood to flow the wrong way
  • People whose affected vein measures more than 3 mm and less than 12 mm across, as confirmed by an ultrasound scan taken while standing
  • Only one leg per person is included in the study
  • People who are willing to sign a consent form and attend all required check-up visits as set out in the study plan

Who may not be able to join:

  • People who have a blood clot in the main leg veins, a deep vein blood clot, or a history of deep vein clots or blood clots in the lungs
  • People whose varicose veins have come back after a previous treatment
  • People whose main leg vein is severely twisted in a way that makes passing a treatment tube through it unlikely to work
  • People with severely reduced blood flow to the lower legs (confirm with trial site)
  • People with a known allergy to any of the medicines or device materials used in this study
  • People who have an implanted pacemaker or defibrillator, or who regularly take blood-thinning medicines such as warfarin or heparin
  • People who are pregnant or breastfeeding
  • People who are unable or unwilling to complete the study questionnaires
  • People currently taking part in another clinical trial for a drug or medical device
  • People with a life expectancy of less than one year
  • People currently receiving treatment for a skin cancer other than non-melanoma skin cancer
  • People who use narcotic drugs or anti-inflammatory painkillers every day to manage pain caused by their vein condition
  • People for whom the treating investigator does not consider this type of vein treatment to be appropriate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-18981885601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chengdu University of Traditional Chinese Medicine
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

6-month postoperative occlusion rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov